KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-09 4:15 pm Sale | 2022-05-31 | 13G | Anika Therapeutics, Inc. ANIK | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 627,321 4.310% | -840,189 (-57.25%) | Filing |
| 2022-02-11 6:27 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,467,510 10.170% | -78,753 (-5.09%) | Filing |
| 2021-02-10 5:49 pm Purchase | 2020-12-31 | 13G | Anika Therapeutics, Inc. ANIK | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,263 10.880% | 48,154 (+3.21%) | Filing |
| 2020-08-17 3:25 pm Purchase | 2020-07-31 | 13G | Anika Therapeutics, Inc. ANIK | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,498,109 10.540% | 28,930 (+1.97%) | Filing |
| 2020-08-05 4:29 pm Purchase | 2020-07-31 | 13G | Anika Therapeutics, Inc. ANIK | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,469,179 10.340% | 85,851 (+6.21%) | Filing |